- Workowski KA, Bachmann LH, Chan PA, Johnston CM, Muzny CA, Park I, et al. Sexually transmitted infections treatment guidelines, 2021. MMWR Recomm Rep. 2021;70(4):1.
- Kombe Kombe AJ, Li B, Zahid A, Mengist HM, Bounda G-A, Zhou Y, et al. Epidemiology and burden of human papillomavirus and related diseases, molecular pathogenesis, and vaccine evaluation. Front Public health. 2021;8:552028.
- Greten FR, Grivennikov SI. Inflammation and cancer: triggers, mechanisms, and consequences. Immunity. 2019;51(1):27-41.
- Tempera I, Lieberman PM. Oncogenic Viruses as Entropic Drivers of Cancer Evolution. Front Virol. 2021;1.
- de Martel C, Georges D, Bray F, Ferlay J, Clifford GM. Global burden of cancer attributable to infections in 2018: a worldwide incidence analysis. Lancet Glob Health. 2020;8(2):e180-e90.
- Monteiro JC, Fonseca RRDS, Ferreira TCDS, Rodrigues LLS, Da Silva ARB, Gomes ST, et al. Prevalence of high risk HPV in HIV-Infected women from Belém, Pará, Amazon region of Brazil: a cross-sectional study. Front Public Health. 2021;9:649152.
- Patzi-Churqui M, Terrazas-Aranda K, Liljeqvist J-Å, Lindh M, Eriksson K. Prevalence of viral sexually transmitted infections and HPV high-risk genotypes in women in rural communities in the Department of La Paz, Bolivia. BMC Infect Dis. 2020;20(1):1-11.
- Magaña‐Contreras M, Contreras‐Paredes A, Chavez‐Blanco A, Lizano M, Cruz‐Hernandez YDl, Cruz‐Hernandez EDl. Prevalence of sexually transmitted pathogens associated with HPV infection in cervical samples in a Mexican population. J Med Virol. 2015;87(12):2098-105.
- Laantri N, Attaleb M, Kandil M, Naji F, Mouttaki T, Belghmi K, et al. Human papillomavirus detection in moroccan patients with nasopharyngeal carcinoma. Infect Agents Cancer. 2011;6(1):1-6.
- Ma X, Yang M. The correlation between high-risk HPV infection and precancerous lesions and cervical cancer. Am J Transl Res. 2021;13(9):10830.
- Kerishnan JP, Gopinath SC, Kai SB, Tang T-H, Ng HL-C, Rahman ZAA, et al. Detection of human papillomavirus 16-specific IgG and IgM antibodies in patient sera: a potential indicator of oral squamous cell carcinoma risk factor. Int J Med Sci. 2016;13(6):424.
- Katar M. Evaluation of tumor marker test requests in a hospital setting. Int J Med Biochem. 2021;4(1):8.
- Ayhan A, Guven S, Seda Guvendag Guven E, Kucukali T. Is there a correlation between tumor marker panel and tumor size and histopathology in well staged patients with borderline ovarian tumors? Acta Obstet Gynecol Scand. 2007;86(4):484-90.
- Jayapalan S, Bindu R. Papanicolaou smear: A diagnostic aid in sexually transmitted infections. Indian J Sex Transm Dis Aids. 2020;41(2):143.
|
